Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Voss

Showing results (261-270 of 276) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantationDonna L Forrest, Donna E Hogge, Thomas J Nevill, et al.
Oncogene|May 20, 1998
Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3GG Posern, J Zheng, B S Knudsen, et al.
Bone Marrow Transplantation|June 26, 1999
Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's diseaseD E Reece, T J Nevill, A Sayegh, et al.
British Journal of Haematology|October 4, 2005
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphomaRichard T Doocey, Cynthia L Toze, Joseph M Connors, et al.
British Journal of Haematology|May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphomaKevin W Song, Michael J Barnett, Randy D Gascoyne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomesK W Song, M J Barnett, R D Gascoyne, et al.
Bone Marrow Transplantation|September 10, 2005
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host diseaseC L Toze, A Galal, M J Barnett, et al.
Bone Marrow Transplantation|August 13, 2008
Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term resultsK M Ramadan, J M Connors, A J Al-Tourah, et al.
Physical Review Letters|June 4, 2008
Determination of the N=16 shell closure at the oxygen drip lineC R Hoffman, T Baumann, D Bazin, et al.
AIDS Care|October 8, 2013
Depressive symptoms, self-esteem, HIV symptom management self-efficacy and self-compassion in people living with HIVL S Eller, M Rivero-Mendez, J Voss, et al.
Pageof 28

Showing results (261-270 of 276) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantationDonna L Forrest, Donna E Hogge, Thomas J Nevill, et al.
Oncogene|May 20, 1998
Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3GG Posern, J Zheng, B S Knudsen, et al.
Bone Marrow Transplantation|June 26, 1999
Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's diseaseD E Reece, T J Nevill, A Sayegh, et al.
British Journal of Haematology|October 4, 2005
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphomaRichard T Doocey, Cynthia L Toze, Joseph M Connors, et al.
British Journal of Haematology|May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphomaKevin W Song, Michael J Barnett, Randy D Gascoyne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomesK W Song, M J Barnett, R D Gascoyne, et al.
Bone Marrow Transplantation|September 10, 2005
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host diseaseC L Toze, A Galal, M J Barnett, et al.
Bone Marrow Transplantation|August 13, 2008
Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term resultsK M Ramadan, J M Connors, A J Al-Tourah, et al.
Physical Review Letters|June 4, 2008
Determination of the N=16 shell closure at the oxygen drip lineC R Hoffman, T Baumann, D Bazin, et al.
AIDS Care|October 8, 2013
Depressive symptoms, self-esteem, HIV symptom management self-efficacy and self-compassion in people living with HIVL S Eller, M Rivero-Mendez, J Voss, et al.
Pageof 28